Most just lately, it has been discovered that conolidine and the above derivatives act within the atypical chemokine receptor three (ACKR3. Expressed in very similar places as classical opioid receptors, it binds to some big range of endogenous opioids. Not like most opioid receptors, this receptor acts like a scavenger and won't activate a second … Read More